pubmed-article:1535433 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1535433 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
pubmed-article:1535433 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
pubmed-article:1535433 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
pubmed-article:1535433 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
pubmed-article:1535433 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:1535433 | pubmed:dateCreated | 1992-7-27 | lld:pubmed |
pubmed-article:1535433 | pubmed:abstractText | Highly sensitive up-to-date research methods (enzyme immunoassay) for HbsAg and antibodies against HBsAg and HBcAg were employed to examine 565 adults and children living in the Kalmuck++ ASSR (Elista and adjacent regions), where in 1988-1989 cases of HIV-infection were recorded. Markers of HBV-infection were detected with a high enough frequency in the control group of children (15.2%). The prevalence of the infection in the adult population was at an intermediate level (38.9%). The high infectivity with HBV-infection was recorded among children who had been hospitalized before (for different diseases including chronic ones), among women who had undergone laboratory studies because of the diagnosis of HIV-infection in their children; among adult patients suffering from tuberculosis of morons from a closed boarding school. The highest frequency of HBV-infection marker demonstration was found in HIV-infected children (70%). The data obtained point to the necessity of vaccination against viral hepatitis B in risk groups (children and adults) and in the newborn as well as of raising the efficacy of preventing measures against infections transmitted via blood. | lld:pubmed |
pubmed-article:1535433 | pubmed:language | rus | lld:pubmed |
pubmed-article:1535433 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535433 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1535433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535433 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1535433 | pubmed:issn | 0031-403X | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:StepanovA NAN | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:SokolovaN VNV | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:Ucha?kinV FVF | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:MolevaT PTP | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:KaganovB SBS | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:KonevV AVA | lld:pubmed |
pubmed-article:1535433 | pubmed:author | pubmed-author:SharaevaN BNB | lld:pubmed |
pubmed-article:1535433 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1535433 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1535433 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1535433 | pubmed:pagination | 56-60 | lld:pubmed |
pubmed-article:1535433 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:meshHeading | pubmed-meshheading:1535433-... | lld:pubmed |
pubmed-article:1535433 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1535433 | pubmed:articleTitle | [Prevalence of hepatitis B in the focus of HIV infection]. | lld:pubmed |
pubmed-article:1535433 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1535433 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1535433 | pubmed:publicationType | English Abstract | lld:pubmed |